Literature DB >> 25937395

In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin.

Ebru Evren1, Erkan Yurtcu.   

Abstract

Limited treatment options in infectious diseases caused by resistant microorganisms created the need to search new approaches. Several herbal extracts are studied for their enormous therapeutic potential. Silymarin extract, from Silybum marianum (milk thistle), is an old and a new remedy for this goal. The purpose of this study is to evaluate the antibacterial and antiadherent effects of silymarin besides biofilm viability activity on standard bacterial strains. Minimal inhibitory concentration (MIC), minimal bactericidal concentration (MBC), antiadherent/antibiofilm activity, and effects on biofilm viability of silymarin were evaluated against standard bacterial strains. MIC values were observed between 60 and >241 μg/mL (0.25->1 mmol/L). Gram-positive bacteria were inhibited at concentrations between 60 and 120 μg/mL. Gram-negative bacteria were not inhibited by the silymarin concentrations included in this study. MBC values for Gram-positive bacteria were greater than 241 μg/mL. Adherence/biofilm formations were decreased to 15 μg/mL silymarin concentration when compared with silymarin-untreated group. Silymarin reduced the biofilm viabilities to 13 and 46 % at 1 and 0.5 mmol/L concentrations, respectively. We demonstrated that silymarin shows antibacterial and antiadherent/antibiofilm activity against certain standard bacterial strains which may be beneficial when used as a dietary supplement or a drug.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25937395     DOI: 10.1007/s12223-015-0399-6

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  38 in total

Review 1.  Biofilm formation: a clinically relevant microbiological process.

Authors:  R M Donlan
Journal:  Clin Infect Dis       Date:  2001-09-20       Impact factor: 9.079

2.  Silymarin: What is in the name...? An appeal for a change of editorial policy.

Authors:  V Simánek; V Kren; J Ulrichová; J Vicar; L Cvak
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

3.  Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.

Authors:  E Walencka; B Sadowska; S Rózalska; W Hryniewicz; B Rózalska
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 4.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

Review 5.  [Fosfomycin: past, present and future].

Authors:  Orhan Baylan
Journal:  Mikrobiyol Bul       Date:  2010-04       Impact factor: 0.622

6.  Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.

Authors:  Zhiming Wen; Todd E Dumas; Sarah J Schrieber; Roy L Hawke; Michael W Fried; Philip C Smith
Journal:  Drug Metab Dispos       Date:  2007-10-03       Impact factor: 3.922

7.  Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases.

Authors:  Marjan Gharagozloo; Elahe N Javid; Abbas Rezaei; Kazem Mousavizadeh
Journal:  Basic Clin Pharmacol Toxicol       Date:  2012-12-24       Impact factor: 4.080

8.  Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

Authors:  Adam Gordon; Daryl A Hobbs; D Scott Bowden; Michael J Bailey; Joanne Mitchell; Andrew J P Francis; Stuart K Roberts
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

Review 9.  Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).

Authors:  Carmen Tamayo; Suzanne Diamond
Journal:  Integr Cancer Ther       Date:  2007-06       Impact factor: 3.279

10.  Multiple effects of silymarin on the hepatitis C virus lifecycle.

Authors:  Jessica Wagoner; Amina Negash; Olivia J Kane; Laura E Martinez; Yaakov Nahmias; Nigel Bourne; David M Owen; Joe Grove; Claire Brimacombe; Jane A McKeating; Eve-Isabelle Pécheur; Tyler N Graf; Nicholas H Oberlies; Volker Lohmann; Feng Cao; John E Tavis; Stephen J Polyak
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

View more
  6 in total

1.  Anti-histaminic Effects of Resveratrol and Silymarin on Human Gingival Fibroblasts.

Authors:  Amir Farzanegan; Mohammad Shokuhian; Soudeh Jafari; Fatemeh Sadeghi Shirazi; Minoo Shahidi
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

2.  Silymarin from Milk Thistle Fruits Counteracts Selected Pathological Changes in the Lenses of Type 1 Diabetic Rats.

Authors:  Weronika Borymska; Maria Zych; Sławomir Dudek; Ilona Kaczmarczyk-Sedlak
Journal:  Nutrients       Date:  2022-03-30       Impact factor: 5.717

3.  Anti-quorum sensing and anti-biofilm activity of Amomum tsaoko (Amommum tsao-ko Crevost et Lemarie) on foodborne pathogens.

Authors:  Md Ramim Tanver Rahman; Zaixiang Lou; Fuhao Yu; Peng Wang; Hongxin Wang
Journal:  Saudi J Biol Sci       Date:  2015-10-09       Impact factor: 4.219

4.  Terpinen-4-ol as an Antibacterial and Antibiofilm Agent against Staphylococcus aureus.

Authors:  Laísa Cordeiro; Pedro Figueiredo; Helivaldo Souza; Aleson Sousa; Francisco Andrade-Júnior; Daianne Medeiros; Jefferson Nóbrega; Daniele Silva; Evandro Martins; José Barbosa-Filho; Edeltrudes Lima
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

5.  Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota.

Authors:  Kateřina Valentová; Jaroslav Havlík; Pavel Kosina; Barbora Papoušková; José Diógenes Jaimes; Kristýna Káňová; Lucie Petrásková; Jitka Ulrichová; Vladimír Křen
Journal:  Metabolites       Date:  2020-01-09

6.  Silymarin Modulates Microbiota in the Gut to Improve the Health of Sow from Late Gestation to Lactation.

Authors:  Shengyu Xu; Xiaojun Jiang; Xinlin Jia; Xuemei Jiang; Lianqiang Che; Yan Lin; Yong Zhuo; Bin Feng; Zhengfeng Fang; Jian Li; Jianping Wang; Zhihua Ren
Journal:  Animals (Basel)       Date:  2022-08-26       Impact factor: 3.231

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.